Biohaven (BHVN) Depreciation and Depletion (2021 - 2026)

Biohaven's (BHVN) quarterly Depreciation and Depletion came in at $708000.0 in Q1 2026, down 30.25% year-on-year from $1.0 million in Q1 2025, and down 26.25% quarter-over-quarter from $960000.0 in Q4 2025.

Biohaven (BHVN) Depreciation and Depletion (2021 - 2026) Analysis & Trends

Biohaven has disclosed Depreciation and Depletion across 6 years of filings, most recently posting $708000.0 for Q1 2026.

  • Depreciation and Depletion for Q1 2026 came in at $708000.0, down 30.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 million (down 4.1% YoY), and the FY2025 annual result was $4.1 million, up 5.53% from the prior year.
  • Depreciation and Depletion came in at $708000.0 for Q1 2026 at Biohaven, down from $960000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.1 million in Q3 2025 to a low of $209000.0 in Q1 2022.
  • The 5-year median for Depreciation and Depletion is $941000.0 (2024), against an average of $794176.5.
  • Across the five-year window, Depreciation and Depletion soared 273.84% in 2022 and sank 30.25% in 2026, its largest moves.
  • Biohaven's Depreciation and Depletion stood at $643000.0 in 2022, then jumped by 47.43% to $948000.0 in 2023, then advanced by 6.01% to $1.0 million in 2024, then retreated by 4.48% to $960000.0 in 2025, then fell by 26.25% to $708000.0 in 2026.
  • The last three Depreciation and Depletion figures came in at $708000.0 (Q1 2026), $960000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 1,395.22
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -1,330.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Biohaven 1.62 Bn 1.27 Bn - 708,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 708,000.00
Mar 31, 2026 708,000.00
Dec 31, 2025 960,000.00
Dec 31, 2025 960,000.00
Sep 30, 2025 1.11 Mn
Sep 30, 2025 1.11 Mn
Jun 30, 2025 1.06 Mn
Jun 30, 2025 1.06 Mn
Mar 31, 2025 1.02 Mn
Mar 31, 2025 1.02 Mn
Dec 31, 2024 1.01 Mn
Dec 31, 2024 1.01 Mn
Sep 30, 2024 1.00 Mn
Sep 30, 2024 1.00 Mn
Jun 30, 2024 977,000.00
Jun 30, 2024 977,000.00
Mar 31, 2024 941,000.00
Mar 31, 2024 941,000.00
Dec 31, 2023 948,000.00
Dec 31, 2023 948,000.00